Impact of functional-related characteristics (FRCs) of crospovidone on tablet disintegration performance.

IF 2.6 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Firas El-Saleh, Hendrik Hübscher, Sergei Trofimov, Christian Muehlenfeld
{"title":"Impact of functional-related characteristics (FRCs) of crospovidone on tablet disintegration performance.","authors":"Firas El-Saleh, Hendrik Hübscher, Sergei Trofimov, Christian Muehlenfeld","doi":"10.1080/10837450.2025.2518568","DOIUrl":null,"url":null,"abstract":"<p><p>Crospovidone, a widely used superdisintegrant, exists in two pharmacopeial grades - Type A (coarser particle size) and type B (finer particle size). The differences in particle size among different crospovidone grades lead to variations in functional related characteristics (FRCs), such as hydration capacity and powder flowability. The present study investigates the relative impact of crospovidone FRCs on tablet disintegration time. Multiple lots of different crospovidone grades were evaluated for their particle size distribution, hydration capacity and powder flowability. Subsequently, tablets were prepared from the different lots of crospovidone and evaluated for their disintegration time. Correlation analyses were performed to evaluate the independent effects of FRCs on disintegration time. While initial correlations showed strong interdependence among particle size, hydration capacity, and powder flowability, the decoupling of particle size as the most impacting factor revealed that hydration capacity and powder flowability had no or only limited impact on the tablet disintegration time.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"1-13"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2025.2518568","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Crospovidone, a widely used superdisintegrant, exists in two pharmacopeial grades - Type A (coarser particle size) and type B (finer particle size). The differences in particle size among different crospovidone grades lead to variations in functional related characteristics (FRCs), such as hydration capacity and powder flowability. The present study investigates the relative impact of crospovidone FRCs on tablet disintegration time. Multiple lots of different crospovidone grades were evaluated for their particle size distribution, hydration capacity and powder flowability. Subsequently, tablets were prepared from the different lots of crospovidone and evaluated for their disintegration time. Correlation analyses were performed to evaluate the independent effects of FRCs on disintegration time. While initial correlations showed strong interdependence among particle size, hydration capacity, and powder flowability, the decoupling of particle size as the most impacting factor revealed that hydration capacity and powder flowability had no or only limited impact on the tablet disintegration time.

功能相关特性(FRCs)对片崩解性能的影响。
交叉聚维酮是一种广泛使用的超级崩解剂,存在两种药典等级——a型(粗粒度)和B型(细粒度)。不同品级间的颗粒大小差异导致了功能相关特性(FRCs)的变化,如水化能力和粉末流动性。本研究考察了交叉维酮FRCs对片剂崩解时间的相对影响。对多批次不同等级的交叉聚维酮的粒径分布、水化能力和粉末流动性进行了评价。随后,以不同批号的交叉维酮为原料制备片剂,并对其崩解时间进行评价。通过相关分析来评价FRCs对崩解时间的独立影响。粒径、水化能力和粉末流动性三者之间存在较强的相关性,但粒径作为最大影响因素的解耦关系表明,水化能力和粉末流动性对片剂崩解时间没有或只有有限的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
2.90%
发文量
82
审稿时长
1 months
期刊介绍: Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology. Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as: -Preformulation and pharmaceutical formulation studies -Pharmaceutical materials selection and characterization -Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation -QbD in the form a risk assessment and DoE driven approaches -Design of dosage forms and drug delivery systems -Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies -Drug delivery systems research and quality improvement -Pharmaceutical regulatory affairs This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信